Akihiro Sudo

10.7k citations
459 papers · 7.5k indexed · h-index 40

Akihiro Sudo

433 papers receiving 7.3k citations

Peers

Akihiro Sudo
Comparison fields: 5 of 150
  • Internal Medicine 531
  • Rheumatology 1.7k
  • Orthopedics and Sports Medicine 790
  • Surgery 2.8k
  • Pharmacology 857
Replace Atsumasa Uchida with:
Atsumasa Uchida Japan
Alan T. Nurden France
Naoto Endo Japan
Paul E. Di Cesare United States
J. R. Levick United Kingdom
Tomoyuki Matsumoto Japan
Paquita Nurden France
C H Rorabeck Canada
Florence Sabatier France
Eleftherios Tsiridis United Kingdom
Akihiro Sudo relative to Atsumasa Uchida Japan Atsumasa Uchida's profile →
Citations per field
00.5×
Atsumasa Uchida · 1×
Citations per year

Countries citing papers authored by Akihiro Sudo

Since Specialization
Citations

This map shows the geographic impact of Akihiro Sudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Sudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Sudo more than expected).

Fields of papers citing papers by Akihiro Sudo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Sudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Sudo. The network helps show where Akihiro Sudo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Akihiro Sudo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Akihiro Sudo Line = papers co-authored together Akihiro Sudo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20244
3 20240
4 20233
5 20232
6 20234
7 20232
8 20231
9 20234
10 20223
11 20220
12 20206
13 20204
14 20209
15 20195
16 20198
17 20194
18 201718
19 20161
20
Role of miR-222-3p in c-Src-Mediated Regulation of Osteoclastogenesis
20161

About Akihiro Sudo

Akihiro Sudo is a scholar working on Internal Medicine, Orthopedics and Sports Medicine and Rheumatology, having authored 459 papers that have together received 7.5k indexed citations. Recurring topics across this work include Orthopaedic implants and arthroplasty (88 papers), Sarcoma Diagnosis and Treatment (84 papers), Total Knee Arthroplasty Outcomes (70 papers), Orthopedic Infections and Treatments (54 papers), Spine and Intervertebral Disc Pathology (43 papers), Venous Thromboembolism Diagnosis and Management (33 papers), Bone Tumor Diagnosis and Treatments (31 papers) and Musculoskeletal pain and rehabilitation (30 papers). The work is most often cited by research in Internal Medicine (531 citations), Rheumatology (1.7k citations) and Orthopedics and Sports Medicine (790 citations). Akihiro Sudo has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Masahiro Hasegawa, Atsumasa Uchida, Tomoki Nakamura, Akihiko Matsumine, Kunihiro Asanuma, Hiroki Wakabayashi, Koji Akeda, Akinobu Nishimura, Rui Niimi and Ko Kato. Their work appears in journals such as Modern Rheumatology, BMC Musculoskeletal Disorders, Cancers, Scientific Reports and International Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026